Maryland Heights, MO – Seventh Wave Laboratories LLC announced a key addition to their team – Magdy H. Abdelhameed, PhD, MBA, has joined the company as senior pharmacokineticist to support their growing portfolio of clients.
Dr. Abdelhameed has extensive experience in designing and executing programs to support drug discovery and development. His experience spans preclinical and clinical pharmaceutical research; he has a solid theoretical and practical background in pharmaco and toxicokinetics, having designed and executed programs while also performing the data evaluations, interpreting the results, and preparing reports for clients and regulators. Magdy earned his Ph.D in Pharmaceutics/Pharmacokinetics from the University of Alexandria, then went on to pursue a career in academia and industry.
Dr. Abdelhameed joins Seventh Wave as Senior Pharmacokineticist to support DMPK studies. “ I am excited to take my drug development experience in Pharmacokinetics/Toxicokinetics to a new level to help our clients bringing their new medicines to market. The culture and environment at Seventh Wave are excellent and I will look forward to being part of this well recognized and well respected team.”
“Pharmacokinetics and preclinical consulting are key components of our service offerings, so we are delighted to have recruited a candidate with Magdy’s expertise and demonstrated programmatic leadership” observed Kris Nikula, CSO of Seventh Wave.
John Sagartz, President and CEO of Seventh Wave said “We were purposeful in our search for another senior scientific team member; the ideal candidate needed a solid background in pharmacokinetics and we also demanded strong communications skills and a client centric mindset. We found all those in Magdy and he’s already had a positive impact to some of our client relationships”